UMass Chan Researchers Launch Clinical Trial for Psychedelic Medication in Adjustment Disorder

Researchers at UMass Chan Medical School are initiating a clinical trial to investigate whether an investigational psychedelic medication, 4-OH-DiPT, can alleviate symptoms of adjustment disorder in individuals diagnosed with serious medical conditions such as cancer, ALS, multiple sclerosis, Parkinson's disease, or idiopathic pulmonary fibrosis. The chemical acts similarly to psilocybin.